Lataa...
Albumin treatment regimen for type 1 hepatorenal syndrome: a dose–response meta-analysis
BACKGROUND: Recommended treatment for type 1 hepatorenal syndrome consists of albumin and vasoconstrictor. The optimal albumin dose remains poorly characterized. This meta-analysis aimed to determine the impact of albumin dose on treatment outcomes. METHODS: Clinical studies of type 1 hepatorenal sy...
Tallennettuna:
| Julkaisussa: | BMC Gastroenterol |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4660686/ https://ncbi.nlm.nih.gov/pubmed/26606982 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12876-015-0389-9 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|